Skip to search formSkip to main contentSkip to account menu

ATR-101

An orally bioavailable agent that is selective towards adrenal cortex cells with potential antitumor activity. Upon administration, ATR-101… 
National Institutes of Health

Related topics

Related topics

1 relation
NCIt Antineoplastic Agent Terminology

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Characterization of clinical, biochemical and adrenal hormonal effects of ATR-101, a selective ACAT1 antagonist, in dogs with naturally-occurring Cushing's syndrome
2015
2015
ATR-101 phase 1 clinical study for adrenocortical carcinoma.
TPS4585 Background: ATR-101 (Atterocor, Inc., Ann Arbor, MI, USA) is a selective inhibitor of ACAT1 (acyl coenzyme A:cholesterol… 
2015
2015
Forme médicamenteuse solide du chlorhydrate de n-(2,6-bis(1-méthyléthyl)phényl)-n'-((1-(4-(diméthylamino) phényl)cyclopentyl)méthyl)urée et compositions, procédés et kits s'y rapportant
Cette invention concerne une nouvelle forme medicamenteuse solide du chlorhydrate de N-(2,6-bis(1-methylethyl)phenyl)-N'-((1-(4… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)